Government medical research fund

Thursday, 07 July, 2005

The Commonwealth Government, through the National Health and Medical Research Council (NHMRC), has announced this year's successful recipients of grants of a total more than A$100 million for leading medical research and clinical trials being conducted at universities and research centres.

The grants would cover a diverse research areas including leukaemia, kidney disease, HIV/AIDS, cancer, maternal health, arthritis and melanoma.

The funding was devided into investment in medical research of $80 million (Program Grant), funding for new equipment totalling $9 million (Standard Equipment Grant), almost $10 million to support existing clinical trials (Development Grant) and grants of $2.5 million for researchers to transform their work into commercial products (Enabling Grant).

More than 60 universities and research institutes have received funding for medical research, clinical trials and/or equipment upgrades including: the University of Sydney; University of NSW; University of Melbourne; Monash University; University of Adelaide; Queensland University of Technology; University of Newcastle; ANU; University of Tasmania; Curtin University of Technology; Flinders University; Murdoch University and Edith Cowan University; Queensland Institute of Medical Research; Peter MacCallum Cancer Centre; Garvan Institute of Medical Research; Baker Heart Research Institute; St Vincent's Institute of Medical Research; Ludwig Institute for Cancer Research; Walter and Eliza Hall Institute; Woolcock Institute of Medical research; and the Australia and New Zealand Intensive Care Society.

The University of Sydney was the largest receipent in the country with around one-fifth (A$22 million) being allocated to various research projects at the insititution.

On a per capita basis, Australia 's research output is twice the OECD average. This calendar year, the Government will invest nearly $500 million in health and medical research.

Related News

Govt proposes cuts to R&D Tax Incentive

The Australian Government has reintroduced legislation that it claims will better target the...

AXT adds Alvéole's cell biology platform to its portfolio

The Alvéole platform allows users to convert an existing microscope into an automated...

Cell death pioneers win CSL Florey Medal

Andreas Strasser and David Vaux provided the first insights into the molecular mechanisms for...

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd